名稱 | mADORA2B/CHO GPCR細(xì)胞 |
型號(hào) | CBP71367 |
報(bào)價(jià) | ![]() |
特點(diǎn) | mADORA2B/CHO |
產(chǎn)品搜索
相關(guān)文章
- 人類白細(xì)胞抗原HLA基因分型標(biāo)準(zhǔn)品
- FLT3標(biāo)準(zhǔn)品簡介
- TSLP靶點(diǎn)藥物細(xì)胞篩選模型
- ATCC、DSMZ細(xì)胞庫簡介
- 羅氏乳腺癌新藥獲英國NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- Nature:繞過Ras激酶“不可成藥性”的抗癌新思路
- IL9細(xì)胞篩選模型
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點(diǎn)
- ATCC細(xì)胞系的細(xì)胞培養(yǎng)步驟
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71367mADORA2B/CHO GPCR細(xì)胞

- 詳細(xì)內(nèi)容
CBP71367 | |
I. Background | |
The adenosine receptors ADORA2B is Gs and Gq/G11-coupled GPCR expressed in the large intestine, cecum, and urinary bladder. ADORA2B receptor mediates relaxation to adenosine in human small coronary arteries which is independent of NO but dependents in part on a K+-sensitive mechanism. Pharmacological or molecular biologic activation of ADORA2B receptor may prevent glomerular remodeling associated with glomerulosclerosis, renal disease, and abnormal growth associated with hypertension and diabetes. | |
II. Introduction | |
Host Cell: | CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | N/A |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for mADORA2B receptor |
Transducer: | Gs |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data | |
Figure 1. NECA efffect on CHO-K1-mA2B-clone 6. |